FI20030130A0 - Seulontamenetelmä - Google Patents

Seulontamenetelmä

Info

Publication number
FI20030130A0
FI20030130A0 FI20030130A FI20030130A FI20030130A0 FI 20030130 A0 FI20030130 A0 FI 20030130A0 FI 20030130 A FI20030130 A FI 20030130A FI 20030130 A FI20030130 A FI 20030130A FI 20030130 A0 FI20030130 A0 FI 20030130A0
Authority
FI
Finland
Prior art keywords
screening method
screening
Prior art date
Application number
FI20030130A
Other languages
English (en)
Swedish (sv)
Inventor
Urmas Arumaee
Li-Ying Yu
Mart Saarma
Original Assignee
Licentia Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Licentia Oy filed Critical Licentia Oy
Priority to FI20030130A priority Critical patent/FI20030130A0/fi
Publication of FI20030130A0 publication Critical patent/FI20030130A0/fi
Priority to US10/543,651 priority patent/US7642047B2/en
Priority to PCT/FI2004/000044 priority patent/WO2004067767A1/en
Priority to EP04706197A priority patent/EP1592803A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
FI20030130A 2003-01-29 2003-01-29 Seulontamenetelmä FI20030130A0 (fi)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FI20030130A FI20030130A0 (fi) 2003-01-29 2003-01-29 Seulontamenetelmä
US10/543,651 US7642047B2 (en) 2003-01-29 2004-01-29 Method of screening cell death modulators
PCT/FI2004/000044 WO2004067767A1 (en) 2003-01-29 2004-01-29 Method of screening cell death modulators.
EP04706197A EP1592803A1 (en) 2003-01-29 2004-01-29 Method of screening cell death modulators.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20030130A FI20030130A0 (fi) 2003-01-29 2003-01-29 Seulontamenetelmä

Publications (1)

Publication Number Publication Date
FI20030130A0 true FI20030130A0 (fi) 2003-01-29

Family

ID=8565462

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20030130A FI20030130A0 (fi) 2003-01-29 2003-01-29 Seulontamenetelmä

Country Status (4)

Country Link
US (1) US7642047B2 (fi)
EP (1) EP1592803A1 (fi)
FI (1) FI20030130A0 (fi)
WO (1) WO2004067767A1 (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106932495B (zh) * 2015-12-29 2021-05-28 深圳翰宇药业股份有限公司 分析氟甲基酮及其有关物质的液相色谱法、流动相和套装

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6696259B1 (en) 1995-11-13 2004-02-24 Licentia Ltd. Assays using glial cell line-derived neurotrophic factor receptors
US5882923A (en) 1996-06-27 1999-03-16 Sariola; Hannu Glial cell line-derived neurotrophic factor regulation of ureteric budding and growth
US6713247B1 (en) 1996-09-03 2004-03-30 Signal Pharmaceuticials, Inc. Human CNS cell lines and methods of use therefor
US7247438B1 (en) * 1997-02-18 2007-07-24 Dana-Farber Cancer Institute Methods of identifying agents which enhance caspase activity
NZ501199A (en) * 1997-05-22 2001-12-21 Carlos F Glial cell line-derived neurotrophic factor receptors (BDNFR-beta)
US6913925B1 (en) * 1998-08-12 2005-07-05 Signal Pharmaceuticals Llc Human mesencephalon cell lines and methods of use therefor
FR2791894B1 (fr) * 1999-04-09 2001-07-13 Inst Nat Sante Rech Med Utilisation d'interferon beta dans le traitement de la tumeur d'ewing
ATE444488T1 (de) * 2000-12-14 2009-10-15 Burnham Inst Non-apoptotische formen des zelltods und verfahren zur modulation

Also Published As

Publication number Publication date
US7642047B2 (en) 2010-01-05
WO2004067767A1 (en) 2004-08-12
US20060057721A1 (en) 2006-03-16
EP1592803A1 (en) 2005-11-09

Similar Documents

Publication Publication Date Title
BRPI0313238A2 (pt) método
DE60220654D1 (de) Musterungsmethode
ATE486670T1 (de) Siebvorrichtung
GB0304993D0 (en) Novel screening method
FI20030963A0 (fi) Erotusmenetelmä
NO20035626D0 (no) Metode
DE60311818D1 (de) Materialprüfverfahren
NO20035401D0 (no) Metode
NO20023358D0 (no) Metode
ATA16232003A (de) Sortierer
EP1669446A4 (en) SCREENING PROCESS
DE602004030793D1 (de) Asynchrones flimmerreduktionsverfahren
FI20030130A0 (fi) Seulontamenetelmä
DE60336113D1 (de) Aufzeichnungsverfahren
NO20030206D0 (no) Screening metode
FR2858986B3 (fr) Tamis
SE0302781D0 (sv) Method
SE0300045D0 (sv) Method
NO20035619D0 (no) Metode
SE0300044D0 (sv) Method
ITMO20030213A0 (it) Apparato di vagliatura
SE0300721D0 (sv) New method
SE0301935D0 (sv) A novel screening method
NO20021887D0 (no) Metode
NO20026287D0 (no) Metode